Industry’s role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Hematology |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2254558 |